BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28331190)

  • 1. Natural killer cell activation contributes to hepatitis B viral control in a mouse model.
    Tong S; Liu G; Li M; Li X; Liu Q; Peng H; Li S; Ren H; Yin W
    Sci Rep; 2017 Mar; 7(1):314. PubMed ID: 28331190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
    Zheng M; Sun R; Wei H; Tian Z
    J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
    Yin W; Xu L; Sun R; Wei H; Tian Z
    Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
    Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
    Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
    Kakimi K; Guidotti LG; Koezuka Y; Chisari FV
    J Exp Med; 2000 Oct; 192(7):921-30. PubMed ID: 11015434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.
    Tjwa ET; van Oord GW; Hegmans JP; Janssen HL; Woltman AM
    J Hepatol; 2011 Feb; 54(2):209-18. PubMed ID: 21095036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
    Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
    Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
    Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
    J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
    Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
    Sun R; Gao B
    Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
    Chen Y; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.
    Li Y; Wang JJ; Gao S; Liu Q; Bai J; Zhao XQ; Hao YH; Ding HH; Zhu F; Yang DL; Zhao XP
    PLoS One; 2014; 9(2):e86927. PubMed ID: 24520324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
    Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
    J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum HBV pregenomic RNA exhibited opposite associations with NKdim and NKbright cell immunity in treatment-naïve chronic hepatitis B patients.
    Gu Y; Huang Z; Li X; Chen Y; Liao C; Bi Y; Huang Y
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
    Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
    Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cell-Derived Interferon-Gamma Promotes Hepatocellular Carcinoma Through the Epithelial Cell Adhesion Molecule-Epithelial-to-Mesenchymal Transition Axis in Hepatitis B Virus Transgenic Mice.
    Chen Y; Hao X; Sun R; Wei H; Tian Z
    Hepatology; 2019 Apr; 69(4):1735-1750. PubMed ID: 30329167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.